Evidence map›Paper›PMID 32733013›Full record

ArticleLeukemia2020

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

G J Ossenkoppele, D A Breems, G Stuessi, Y van Norden, M Bargetzi, B J Biemond, P A von dem Borne, Y Chalandon, J Cloos, D Deeren and 24 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 4 countries.

G J OssenkoppeleAmsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands. g.ossenkoppele@amsterdamumc.nl.
D A BreemsNetwerk Antwerpen, Antwerp, Belgium.
G StuessiBellinzona-IOSI, Bellinzona, Switzerland.
Y van NordenHOVON Data Center, Erasmus MC-Department of Hematology, Rotterdam, The Netherlands.
M BargetziAarau-Kantonsspital, Aarau, Switzerland.
B J BiemondAmsterdam University Medical Center, location AMC, Amsterdam, Netherlands.
P A von dem BorneLeiden University Medical Center, Leiden, Netherlands.
Y ChalandonUniversity Hospital and University of Geneva, Genève, Switzerland.ORCID http://orcid.org/0000-0001-9341-8104
J CloosAmsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands.
D DeerenRoeselare-AZ Delta, Roeselare, Belgium.
M FehrSt Gallen-Kantonnsspital, St. Gallen, Switzerland.
B GjertsenHaukeland University Hospital, Bergen (N), Norway.
C GrauxYvoir-MontGodinne, Yvoir, Belgium.
G HulsUniversity Medical Center, Groningen, Netherlands.
J J J W JanssenAmsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands.
A JaspersHôpital Citadelle, Liège (B), Belgium.
M Jongen-LavrencicErasmus University Medical Center, Rotterdam, Netherlands.
E de JonghDordrecht ASZ, Dordrecht, Netherlands.
S K KleinMeander Medical Center, Amersfoort, Netherlands.
M van der KliftAmphia-Breda, Breda, Netherlands.
M van Marwijk KooyIsala Hospital, Zwolle, Netherlands.
J MaertensHospital Gasthuisberg, Leuven (B), Belgium.
L MichauxCenter for Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.
M W M van der PoelMaastricht University Medical Center, Maastricht, Netherlands.
A van RhenenUMC Utrecht, Utrecht, Netherlands.
L TickMaximaMC Eindhoven, Eindhoven, Netherlands.
P ValkHôpital Citadelle, Liège (B), Belgium.
M C VekemansHôpital St Luc, Bruxelles, Belgium.
W J F M van der VeldenRadboudumc Nijmegen, Nijmegen, Netherlands.
O de WeerdtSt Antonius Hospital, Nieuwegein, Netherlands.
T PabstDepartment of Oncology, University Hospital, Inselspital and University of Bern, Bern, Switzerland.
M ManzUniversity Hospital, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-4676-7931
B LöwenbergHôpital Citadelle, Liège (B), Belgium.
Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK)
Erasmus MC · NLAmsterdam University Medical Centers · NLRadboud University Nijmegen · NLCentre hospitalier régional de la Citadelle · BEAmphia Ziekenhuis · NLUniversity Medical Center Utrecht · NLCHU Dinant Godinne UCL Namur · BEKantonsspital St. Gallen · CHAZ Delta · BECliniques Universitaires Saint-Luc · BEHaukeland University Hospital · NOIsala · NLKantonsspital Aarau · CHLeiden University Medical Center · NLMeander Medisch Centrum · NLMedisch Centrum Leeuwarden · NLOspedale San Giovanni Bellinzona · CHProvince of Antwerp · BEUniversitair Ziekenhuis Leuven · BEUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32733013
OpenAlexW3046016793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.